Back
X4 Pharmaceuticals Stock Predictions
This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
31
XFOR
X4 Pharmaceuticals
Last Price:
$3.39
Seasonality Move:
-32.92%
7 Day Trial
ALL ACCESS PASS
$
7
Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatioX4 Pharmaceuticals Stock Forecast
-
Is X4 Pharmaceuticals Stock Undervalued?The current X4 Pharmaceuticals [XFOR] share price is $3.39. The Score for XFOR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
XFOR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will X4 Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
X4 Pharmaceuticals Stock Rating
Data Unavailable
X4 Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
x4pharma.com
52-Week Data
52-Week High:
33.90
52-Week Low:
2.67
Prediction Charts
Market Cap:
19.6M
Price in USD:
3.39
Volume:
202.6K
Beta:
0.64
Technical Analysis
SMA50:
5.53
SMA100:
10.32
SMA200:
13.95
52-Wk Change:
-87.49%
Stock Predictions
-
Is X4 Pharmaceuticals stock public?Yes, X4 Pharmaceuticals is a publicly traded company.
-
What is the X4 Pharmaceuticals stock quote today?The X4 Pharmaceuticals stock price is 3.39 USD today.
-
How to buy X4 Pharmaceuticals stock online?You can buy X4 Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-7 | 3.32 | 3.24 | 3.41 | 3.21 |
| May-8 | 3.26 | 3.29 | 3.36 | 3.21 |
| May-9 | 3.44 | 3.37 | 3.44 | 3.14 |
| May-12 | 3.43 | 3.34 | 3.51 | 3.17 |
| May-13 | 3.35 | 3.31 | 3.40 | 3.23 |
| May-14 | 3.39 | 3.24 | 3.48 | 3.19 |
| May-15 | 3.20 | 3.02 | 3.23 | 2.98 |
| May-16 | 3.02 | 2.92 | 3.07 | 2.90 |
| May-19 | 2.95 | 2.92 | 3.00 | 2.84 |
| May-20 | 2.92 | 2.71 | 2.92 | 2.67 |
| May-21 | 2.69 | 2.77 | 2.79 | 2.68 |
| May-22 | 2.72 | 3.23 | 3.38 | 2.70 |
| May-23 | 3.26 | 3.10 | 3.26 | 3.00 |
| May-27 | 3.13 | 3.39 | 3.53 | 3.13 |
X4 Pharmaceuticals Earnings
Data Unavailable
X4 Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $2.17 per share, an increase next quarter of $0.75 per share, a decrease this year of $4.92 per share, and a decrease next year of $2.29 per share.
* X4 Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.